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Abstract
Background: Olig1 is a basic helix-loop-helix (bHLH) transcription factor that is essential for oligodendrogenesis and
efficient remyelination. However, its role in neurodegenerative disorders has not been well-elucidated.
Methodology/Principal Findings: Here we investigated the effects of Olig1 deficiency on experimental autoimmune
encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). We show that the mean disease onset of myelin
oligodendrocyte glycoprotein (MOG)-induced EAE in Olig1
2/2 mice is significantly slower than wide-type (WT) mice
(19.862.2 in Olig1
2/2 mice and 9.560.3 days in WT mice). In addition, 10% of Olig1
2/2 mice did not develop EAE by the
end of the observation periods (60 days). The severity of EAE, the extent of demyelination, and the activation of microglial
cells and astrocytes in spinal cords, were significantly milder in Olig1
2/2 mice compared with WT mice in the early stage.
Moreover, the visual function, as assessed by the second-kernel of multifocal electroretinograms, was better preserved, and
the number of degenerating axons in the optic nerve was significantly reduced in Olig1
2/2 mice. Interestingly, Olig1
deficiency had no effect on T cell response capability, however, it reduced the expression of myelin proteins such as MOG,
myelin basic protein (MBP) and myelin-associated glycoprotein (MAG). The expression of Olig2 remained unchanged in the
optic nerve and brain, and it was reduced in the spinal cord of Olig1
2/2 mice.
Conclusions/Significance: Our results suggest that the Olig1 signaling pathways may be involved in the incidence rate and
the severity of neurological symptoms in MS.
Citation: Guo X, Harada C, Namekata K, Mitamura Y, Yoshida H, et al. (2010) Delayed Onset of Experimental Autoimmune Encephalomyelitis in Olig1 Deficient
Mice. PLoS ONE 5(9): e13083. doi:10.1371/journal.pone.0013083
Editor: Alain Che ´dotal, Institut de la Vision, France
Received April 22, 2010; Accepted September 3, 2010; Published September 29, 2010
Copyright:  2010 Guo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (X.G., K.N., T.H.); Japan Society for
the Promotion of Science for Young Scientists (C.H.); the Welfare and Health Funds from Tokyo Metropolitan Government (Y.M.); the Ministry of Health, Labour,
and Welfare of Japan (Y.M., T.H.); and the Japan Medical Association (T.H.). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: harada-tk@igakuken.or.jp
Introduction
Multiple sclerosis (MS) is an inflammatory disease of the central
nervous system (CNS) characterized by progressive immune-
mediated destruction of the myelin sheath. The inflammatory
process is thought to be mediated in part by T lymphocytes and
microglia/macrophage that are recruited to the CNS in response
to chemotactic signals [1]. In MS, remyelination is an inconsistent
event though there are substantial numbers of oligodendrocyte
progenitor cells (OPCs) observed in the lesion sites [2–5]. Thus,
understanding the molecular mechanisms of remyelination and
the factors related to the limitations of remyelination is particularly
important to identify potential therapeutic targets for repair.
Recent studies have demonstrated that some developmental
pathways that restrict oligodendrocyte maturation, such as
signaling mediated by Notch and Lingo-1, are re-expressed during
MS [6–8]. One important complication in MS is optic neuritis,
which is an acute inflammatory demyelinating syndrome of the
CNS. Since it can cause severe visual loss that is currently
irreversible, especially in the optic-spinal form of MS or
neuromyelitis optica (NMO) [9,10], it draws much attention to
finding a treatment that will restore the visual function.
Olig1 is a basic helix-loop-helix (bHLH) transcription factor
expressed in mature oligodendrocytes, the myelinating cells of
the CNS, and their progenitor cells in the developing CNS
[11,12]. Targeted disruption of Olig1 indicated that Olig1 plays
important roles during the development and maturation of
oligodendrocytes [13]. Olig1 is localized in the nucleus during
the development phase and may function as a transcriptional
regulator for myelin-specific gene expression such as myelin
oligodendrocyte glycoprotein (MOG), myelin basic protein
(MBP) and myelin-associated glycoprotein (MAG) [12,14]. In
addition, Olig1 might be required for remyelination in the adult
brain and spinal cord [12]. Indeed, a previous study using toxin-
induced demyelination models in Olig1
2/2 mice demonstrated
that Olig1 function is essential for the remyelination phase of
both cuprizone- and lysolecithin-induced demyelination in brain
and spinal cord, respectively [13]. These results suggest a critical
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e13083Figure 1. Delayed EAE disease onset in Olig1
2/2 mice. (A) EAE disease incidence in wild-type (WT; n=17) and Olig1
2/2 (n=20) mice. (B) Clinical
evaluation of WT and Olig1
2/2EAE mice during a period of 60 days after MOG immunization. (C) Clinical scores of WT and Olig1
2/2EAE mice in different stages.
doi:10.1371/journal.pone.0013083.g001
Figure 2. Histopathology of the spinal cords in EAE mice. Representative histology of the spinal cords of WT (A) and Olig1
2/2 mice (B) in d10,
d20 and d60. Lumbar spinal cords were stained with luxol fast blue (LFB) and hematoxylin and eosin (HE) (upper panels) and either an anti-GFAP
(middle panels) or anti-iba1 antibody (lower panels). Scale bar: 200 mm and applies to all panels.
doi:10.1371/journal.pone.0013083.g002
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biological functions are not fully understood.
In the present study, we investigated the effects of Olig1
deficiency on experimental autoimmune encephalomyelitis
(EAE), an animal model of MS. There are two Oligl
2/2 mouse
lines available currently, one with a PGKneo cassette and the
other with this cassette removed [12,14]. Mice with the PCKneo
cassette are viable while mice without the PGKneo cassette die
prematurely at around postnatal day (P) 14, or they do not
survive beyond P17[14].It hasbeen suggested that thepresence
of PGKneo in the Olig1 locus may induce increased Olig2
expression that compensates for the Olig1 deficiency and thus,
allowing the mice to survive. However, the reason for this
discrepancy in these two Oligl
2/2 mouse lines is still unclear. In
the present study, we have used Oligl
2/2 mice with the PGKneo
cassette. Considering the delayed remyelination in toxin-
induced demyelination models [13], we expected that the
severity of EAE in Olig1
2/2 mice might be greater than WT
mice. However, our present study revealed a delayed onset of
EAE and mild neurological symptoms in Olig1
2/2 mice. We
also examined the visual function by multifocal electroretino-
grams, a non-invasive method, in order to provide an insight
into the pathology of optic neuritis, which is often associated
with MS/EAE.
Results
Effect of Olig1 deficiency on EAE disease onset, incidence
and severity
The mice were observed for a period of 60 days after MOG
immunization. As shown in Figure 1A, wild-type (WT) mice started
to show EAE disease signs 7 days after disease induction, and
reached an incidence of 100% in 9.560.3 days (n=17). However, a
significant delay of disease onset was found in Olig1
2/2 EAE mice
with a mean disease onset day of 19.862.2 (n=18,P,0.001). More
interestingly, 10% of Olig1
2/2 m i c ed i dn o td e v e l o pE A Eb yt h e
end of the observation period. Daily clinical scoring revealed that
the severity of EAE was significantly milder in Olig1
2/2 mice
compared with WT mice before day 50, except for the period
between days 36–44 (Figure 1B). However, the severity of
Olig1
2/2 EAE mice became comparable with WT EAE mice by
the end of the experiment (Figure 1B). The clinical scores of
Olig1
2/2 E A Em i c ea tv a r i o u st i m ep o i n t sw e r es u m m a r i z e di n
Figure 1C.
We then examined the spinal cords histopathologically at
different time points (Figure 2). Numerous cell infiltrates were
observed in the spinal cord of the WT EAE mice on day 10, while
almost no cell infiltrates were found in Olig1
2/2 EAE mice at this
time point (upper panels in Figure 2A and 2B). Furthermore, on
Figure 3. Quantification of histopathology of the spinal cords in EAE mice. Quantitative analysis of the extent of demyelination (A), GFAP-
positive (B) and iba1-positive (C) cells in the spinal cord. The areas of demyelinated regions in the white matter were measured by ImageJ 1.43u and
expressed as a percentage of the whole area of the white matter. GFAP- and iba1-positive cells were counted per unit area (0.143 mm
2) in the middle
region of the ventral horn. ***P,0.001; **P,0.01; *P,0.05.
doi:10.1371/journal.pone.0013083.g003
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spinal cords of the EAE mice (upper panels in Figure 2A, 2B and
3A), which were much milder in Olig1
2/2 mice compared with
WT mice. However, on day 60, the extents of demyelination and
cell infiltrate were comparable between the two genotypes (upper
panels in Figure 2A, 2B and 3A). Since EAE induction also
induces the activation of astrocytes and microglia [15], we next
investigated the effect of Olig1 deficiency on the extent of
neuroinflammation. Both astrocyte and microglia remained
inactivated on day10 in Olig1
2/2 EAE mice, and when activated,
their activation were milder compared with WT EAE mice on day
20 (middle and lower panels in Figure 2A, 2B and 3B, 3C). This
difference between the two genotypes diminished again on day 60.
We also performed immunohistochemical analysis to determine
whether Olig1 deficiency affects the number of oligodendrocytes and
oligodendrocyte progenitor cells (OPCs) in the white matter of the
spinal cord during EAE. The number of CC1-positive mature
oligodendrocytes was clearly reduced in both of WT and Olig1
2/2
EAE mice on d60 after MOG-immunization (upper panels in
Figure 4A and 4B).No significantdifference wasobserved between the
two genotypes (Figure 4B). On the other hand, the number of OPCs,
as demonstrated with PDGFR-a staining, was significantly increased
upon EAE induction (lower panels in Figure 4A and 4B). However,
there was also no difference between the two genotypes (Figure 4B).
Effect of Olig1 deficiency on optic neuritis
As MS often induces visual disturbance, especially in the optic-
spinal form of MS or neuromyelitis optica (NMO) [9,10], we next
examined the effect of Olig1 deficiency on the severity of optic
neuritis from both the physiological and histopathological aspects.
To this aim, we first investigated the visual functions of EAE mice
using multifocal electroretinograms (mfERGs), an established
noninvasive method for effectively measuring visual function
[16,17]. The response topography demonstrated that the visual
function of WT EAE mice was impaired in all visual fields, but it
was clearly better preserved in Olig1
2/2 EAE mice (Figure 5A).
Furthermore, quantitative analysis revealed that the visual
function in Olig1
2/2 EAE mice (6.9160.69 nV/deg
2; n=6) was
significantly better than WT EAE mice (4.1960.70 nV/deg
2;
n=6)(P=0.032, Figure 5B).
Histopathological analysis revealed that in WT EAE mice,
numerous inflammatory cells infiltrated into the optic nerve lesion
(upper two panels in Figure 6A). However, the number of cell
infiltrates was significantly reduced in Olig1
2/2 EAE mice
(Figure 6B). In addition, the extent of demyelination was clearly
mild in Olig1
2/2 EAE mice. To further analyze morphological
changes in the optic nerve, NF200-stained sections and semithin
transverse sections were observed under a microscope. The level of
NF200 staining for intact axons was largely reduced (third panels
in Figure 6A), indicating severe nerve fiber damage in WT EAE
mice. In contrast, the NF200 staining in Olig1
2/2 EAE mice was
more intense than WT EAE mice (third panels in Figure 6A),
indicating a higher rate of surviving axons in Olig1
2/2 EAE mice.
Moreover, the degenerating axons had abnormally dark axonal
profiles and the density of axons through the optic nerve was
declined in WT EAE mice, but the number of degenerating axons
was clearly reduced in Olig1
2/2 EAE mice (lower panels in
Figure 6A, 6C). Taken together, these data demonstrate that Olig1
deficiency attenuates both the histological and functional aspects
of EAE-induced optic neuritis.
Reduced MOG expression in Olig1 deficient mice
We then investigated the mechanisms leading to the delayed
onset of EAE and attenuated optic neuritis in Olig1
2/2 mice.
Figure 4. The effect of Olig1 deficiency on the number of oligodendrocytes and their progenitor cells during EAE. (A) Representative
immunostaining of CC1 and PDGFR-a in the white matter of the spinal cord. Scale bar: 40 mm and applies to all panels. (B) Quantitative analysis of
mature oligodendrocytes and their progenitor cells. *P,0.001. OLG, oligodendrocyte; OPC, oligodendrocyte progenitor cell.
doi:10.1371/journal.pone.0013083.g004
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assessed the effect of Olig1 deficiency on T-cell proliferation
capability. Freshly isolated T cells from WT and Olig1
2/2 MOG-
immunized mice were stimulated with different concentrations of
MOG. However, no significant difference of T cell proliferation
response was found between WT and Olig1
2/2 mice (Figure 7A).
We also examined whether Olig1 was expressed in the major
immune organs. RT-PCR analysis revealed strong expression of
Olig1 mRNA in the spinal cord and brain (Figure 7B). However,
no mRNA expression was found in the lymph node, spleen and
thymus (Figure 7B), which further suggests that delayed disease
onset of Olig1
2/2 EAE mice was independent of T cell response.
Olig1 may function as a transcriptional regulator for myelin-
specific gene expression. Interestingly, transcriptome profile
analysis of optic nerves from Olig1
2/2 mice without the PGKneo
cassette revealed a large amount of reductions of some myelin
protein transcripts including MBP, MAG and MOG [13,18]. We
then investigated the expression of myelin proteins in Olig1
2/2
mice with the PGKneo cassette [12], which are the mouse line used
in the present study. Western blotting analysis was carried out on
tissues including the optic nerve, spinal cord and brain, which
were isolated from non-EAE 6 week- (the age when EAE was
induced) and 15 week- (the age when EAE mice were sacrificed)
old mice (Figure 8). Among the myelin proteins investigated,
expression levels of MOG, MBP and MAG, except that of
CNPase, were significantly attenuated in 6 week-old Olig1
2/2
mice compared with age-matched WT mice. In addition, a similar
trend was also detected in 15 week-old Olig1
2/2 mice compared
with WT mice. One intriguing point is that the expression level of
PLP was attenuated significantly in the brain, but not in the optic
nerve and spinal cord of 6 week-old Olig1
2/2 mice. Moreover,
the expression level of PLP in the brain became comparable
between 15 week-old WT and Olig1
2/2 mice, which indicated
that the process of PLP expression to reach its optimal level might
be delayed in the Olig
2/2 mice.
As already mentioned earlier, the reason for survival of the
Olig1
2/2 mice with the PGKneo cassette, as opposed to the mice
without it, has been speculated to be due to the compensatory
mechanisms induced by increased Olig2 expression [12].
Considering the significance for confirming this speculation, it
is surprising that Olig2 expression in Olig
2/2 mice has never
been reported in the literature so far. Hence, we have studied
Olig2 expression levels in the tissues isolated from 6 and 15 week-
old WT and Olig1
2/2 mice with the PGKneo cassette.
Interestingly, on the contrary to what had been suggested, the
Olig2 protein expression remained unchanged in the optic nerve
and brain, while it was significantly reduced in the spinal cord of
Olig1
2/2 mice (Figure 9A). Quantitative real-time PCR analysis
of Olig2 in the spinal cord further confirmed this attenuation
(Figure 9B).
Figure 5. Attenuated impaired visual function in Olig1
2/2 EAE mice. (A) The averaged visual responses from six WT and Olig1
2/2 mice were
examined by multifocal electroretinograms (mfERGs). The visual stimulus was applied to seven different areas in the retina. The seven individual
traces demonstrate the average responses to the visual stimulus at the corresponding stimulus area (upper panels). The degree of retinal function is
presented in the color bar. The higher score (red) indicates highly sensitive visual function and lower score (green) indicates retinal dysfunction.
Values are given in nV per square degree (nV/deg
2). (B) Quantitative analysis of the visual response amplitude. The sum of the response amplitudes
for each stimulus element was divided by the total area of the visual stimulus. *P,0.05.
doi:10.1371/journal.pone.0013083.g005
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Olig1 is an important transcript factor expressed in mature
oligodendrocytes and their progenitor cells, however, the biolog-
ical functions of Olig1 are not fully elucidated. In the present
study, we examined the effect of Olig1 deficiency on EAE and
optic neuritis, which is one of the presenting signs of MS. We
hypothesized that the clinical signs of Olig1
2/2 EAE mice might
be more severe than WT EAE mice based on the results from the
toxin-induced demyelination models [13]. However, Olig1
2/2
mice displayed delayed onset of EAE, and the clinical signs of
Olig1
2/2 EAE mice became comparable with WT EAE mice
only in the late phase. Moreover, in contrast to the previous
assumption [13], the numbers of mature oligodendrocytes and
OPCs were not decreased in Olig1
2/2 EAE mice. The
remyelination process in EAE models is much less obvious
compared with the chemical models of toxin-induced demyelin-
ation, which may have hampered the detection of subtle changes
in the number of oligodendrocytes and OPCs. Furthermore, Olig1
deficiency attenuated optic neuritis induced by EAE. Since T cell
response was unaffected by Olig1 deficiency, we speculate that
reduced MOG expression in the spinal cord and optic nerve might
contribute to the observed phenotype of Olig1
2/2 EAE mice.
The pathogenic changes underlying autoimmune disorders are
thought to be initiated and driven by T cell populations that
recognize and respond to autoantigens [19]. In a study to
demonstrate the immunological basis for MOG, MOG deficient
(MOG
2/2) mice exhibited no clinical or histological abnormalities
when immunized with recombinant MOG, or with the MOG 35–
55 peptide sequence [20]. Moreover, although MOG accounts for
only about 0.1% of total CNS myelin protein, MOG
2/2 mice
showed a delayed onset of EAE when immunized with whole
myelin and the clinical signs were significantly milder compared
with WT mice, suggesting that anti-MOG response is the major
pathogenic component of the autoimmune response directed
against myelin. Thus, it seems to be logical that reduced MOG
expression in the Olig1
2/2 mice might largely contribute to the
delayed onset of EAE. On the other hand, multiple antigen
Figure 6. Representative histopathology of the optic nerves in EAE mice. (A) Optic nerves were stained with luxol fast blue (LFB) and
hematoxylin and eosin (HE) (upper two panels) or NF200 and toluidine blue for the semithin transverse sections (lower two panels). The arrows point
to the degenerating axons. Scale bar: 100 mm for the first and third panels, 75 mm for the second panels and 15 mm for the lower panels. (B)
Quantitative analysis of cell infiltrates in the longitudinal section of the optic nerve. (C) Quantitative analysis of degenerating axons in the transverse
section of the optic nerve. *P,0.01.
doi:10.1371/journal.pone.0013083.g006
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the autoantigen in spontaneous autoimmunity, a transgenic mouse
expressing a MOG-specific T cell receptor was investigated [19].
As predicted, the mice developed spontaneous EAE in the
presence of MOG, but they also developed EAE in the absence
of MOG due to recognition of a non-MOG autoantigen
corresponding to an epitope on neurofilament-M. The authors
refer to the recognition of multiple independent autoantigens by a
single T cell population as cumulative autoimmunity and suggest
that these additive responses contribute to particularly vigorous
immune reactions and may play a role in spontaneously
developing autoimmune disorders in humans. Therefore, the
reduced expressions of MBP and MAG in Olig1
2/2 mice might
also contribute to the delayed onset of EAE. One point to note is
that the CNPase and PLP expressions in the optic nerve and spinal
cord remained unchanged although the expressions of MOG,
MBP and MAG were all reduced in Olig1
2/2 mice, which might
be explained by the possibility that the CNPase and PLP
expressions are only weakly regulated by Olig1.
Since the expression levels of MOG, MAG and MBP were
reduced (Figure 8), one might expect that there is less myelination
in Olig1
2/2 axons. However, there was no difference in the
structure of the myelin in the spinal cord and optic nerve between
non-EAE Olig1
2/2 mutants and WT mice (Figure 2 and 6). These
findings are consistent with the initial report on the characteriza-
tion of these mutant mice, in which it demonstrated this mouse
line undergoes normal development [12]. There is a hypothesis
that increased Olig2 expression compensates for the Olig1
deficiency. However, our data demonstrated that Olig2 expression
remained unchanged in the optic nerve and brain, and in fact, it
attenuated in the spinal cord in Olig1
2/2 mice (Figure 9). It will
be intriguing to investigate other candidate genes that may be
responsible for the survival of this Olig1
2/2 mouse line. One
explanation for the unaltered myelin formation despite the altered
level of MOG, MAG and MBP might be that the extent of
reduction, which is subtle compared with the large reductions
observed in the mice without the PGKneo cassette [18], was not
enough to induce a significant change in the myelin formation
during development. This speculation can be supported by the
observation that not all myelin protein levels were affected; we
have shown in this study that the expression levels of CNPase
and PLP were unchanged in non-EAE adult Olig1
2/2 mice
(Figure 8). If there was in fact less myelination in these mice, it
would be logical to expect that they should be more susceptible to
E A Ei n d u c t i o n .H o w e v e r ,o nt h ec o n t r a r y ,o u rr e s u l t sd e m o n -
strated that these mice had reduced EAE severity in the early
phase of the experiment (Figure 1B). Hence, reduced expressions
of MOG, MBP and MAG did not impair myelin formation
during development, but contributed to alleviate EAE signs in
Olig1
2/2 mice.
Genetic ablation of some genes has been reported to have
significant effects on the disease onset of EAE. For example,
MyD88
2/2 mice were reported to be completely EAE resistant
[21]. In addition, TLR9
2/2 and TNF
2/2 mice demonstrated a
significant delay in EAE disease onset relative to WT mice [21,22].
However, all of these onset delays were derived from the effects of
the genetic ablation on the response of dendritic cells or T cells,
which is different from the effects of Olig1 deficiency on myelin
protein expressions observed in the present study. Thus, our results
may have importance in the path to searching for factors
responsible for the pathogenesis of MS other than such cell
responses in the immune system.
In the present study, the results from the second-order kernel of
mfERGs, which is a sensitive indicator of visual function [16,17],
demonstrated that the degree of visual impairment in Olig1
2/2
EAE mice in vivo was less than WT EAE mice. Currently,
corticosteroid is the only treatment option available for acute
demyelinating optic neuritis, but future therapies could include
downregulation of Olig1 as well as use of neuroprotective agents
[16,23]. The study by Arnett et al. demonstrated that Olig1
function is essential for the remyelination phase of both cuprizone-
and lysolecithin-induced demyelination in brain and spinal cord,
respectively [13]. Combining these data with our data, one may
speculate that downregulation of Olig1 during inflammation and
upregulation of Olig1 in the remyelination phase may prove to be
one of the useful strategies against demyelinating diseases.
In addition to the expression in oligodendrocytes, Olig1 has also
been demonstrated to be expressed in a subset of astrocytes [24].
Since GFAP expression was significantly upregulated in the spinal
cord of EAE mice and chemokine released from astrocytes was
implicated in the pathogenesis of EAE, it will be intriguing to
elucidate the possible effects of Olig1 in astrocytes on microglia
cell responses during EAE. On the other hand, it was hypothesized
that genetic variants in the Olig1 gene might influence
remyelinating capacity and vulnerability to the consequences of
a demyelinating event [25]. Although some coding variants in the
Olig1 gene have been identified in patients with MS [26], there is
still no evidence to support this hypothesis. In the present study,
we demonstrate that Olig1 deficiency, or reduced expression of
MOG, MBP and MAG caused by Olig1 deficiency, delayed the
onset of EAE. Thus, Olig1 signaling pathways may be involved in
Figure 7. The effect of Olig1 deficiency on T cell proliferation
capability. (A) Proliferative responses of MOG-specific T cells isolated
from WT and Olig1
2/2 EAE mice (n=4). (B) RT-PCR analysis of Olig1
expression in brain, spinal cord, lymph node, spleen and thymus of WT
mice.
doi:10.1371/journal.pone.0013083.g007
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MS. Modulation of Olig1 and myelin protein expression levels
may provide novel therapeutic opportunities for MS.
Materials and Methods
Ethics Statement
All mice experiments were approved by the Tokyo Metropol-
itan Institute for Neuroscience Committee for Animal Research
(permit number; 22-01/institutional review board; Dr. Norio
Ishizuka).
Mice
Olig1
2/2 mice and the control WT mice are on the same
C57BL/6J background. Olig1
2/2 mice were generated as
described [12]. Female WT and Olig1
2/2 mice were maintained
at the animal facilities of the Tokyo Metropolitan Institute for
Neuroscience and were 6–8 weeks of age at the time of
immunization.
Induction and assessment of EAE
EAE was induced with rat myelin oligodendrocyte glycopro-
tein (MOG)35–55 peptide (MEVGWYRSPFSRVVHLYRNGK)
as previously reported [15,16]. Briefly, mice were subcutane-
ously injected with 100 mgo fM O G 35–55 mixed with 500 mgo f
heat-killed Mycobacterium tuberculosis H37RA (Difco, Detroit,
MI, USA) emulsified in complete Freund’s adjuvant. Each
mouse also received intraperitoneal injections of 500 ng
pertussis toxin (Seikagaku, Tokyo, Japan) immediately and
48 h after the immunization. Clinical signs were scored daily as
follows: 0, no clinical signs; 1, loss of tail tonicity; 2, flaccid tail;
3, impairment of righting reflex; 4, partial hind limb paralysis;
5, complete hind limb paralysis; 6, partial body paralysis; 7,
partial forelimb paralysis; 8, complete forelimb paralysis or
m o r i b u n d ;9 ,d e a t h .
Histopathology and immunohistochemistry
Optic nerves and spinal cords were examined on day 10, day 20
and day 60 after MOG immunization as previously reported
[15,16]. Sections were stained with luxol fast blue (LFB) followed
by hematoxylin and eosin (HE). Transversal semithin (500 nm)
sections of optic nerve were stained with toluidine blue [17].
Immunohistochemistry was performed using the following prima-
ry antibodies: rabbit anti-iba1 (1.0 mg/ml) [27], mouse anti-GFAP
(50 mg/ml; Progen, Toowong, Australia), mouse anti-CC-1 (1:100;
Calbiochem, Gibbstown, NJ, USA), rabbit anti-PDGFR-a (1:200;
Santa Cruz, Santa Cruz, CA, USA) and mouse anti-NF200 (1:400;
Sigma, St. Louis, MO, USA). Quantitative analysis of immuno-
positive cell number or stained region was carried out using NIH
Image (ImageJ 1.43u).
Figure 8. Myelin protein expression levels in Olig1
2/2 mice. The expression of MOG, MBP, MAG, PLP and CNPase in the tissues was
investigated by Western blotting. Tissues were isolated from 6 week- and 15 week-old WT and Olig1
2/2 mice. ***P,0.001; **P,0.01; *P,0.05.
doi:10.1371/journal.pone.0013083.g008
Figure 9. Olig2 expression levels in Olig1
2/2 mice. (A) The expression of Olig2 in the tissues was investigated by Western blotting. Tissues were
isolated from 6 week- and 15 week-old WT and Olig1
2/2 mice. (B) Quantitative real-time PCR analysis of Olig2 mRNA in the spinal cord. **P,0.01;
*P,0.05.
doi:10.1371/journal.pone.0013083.g009
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mfERGs were measured in various time points after MOG
immunization as previously reported [16,17]. Briefly, mice were
anesthetized by an intraperitoneal injection of a mixture of
xylazine (10 mg/kg) and ketamine (25 mg/kg). Pupils were dilated
with 0.5% phenylephrine hydrochloride and 0.5% tropicamide.
mfERGs were recorded using a VERIS 6.0 system (Electro-
Diagnostic Imaging, Redwood City, CA, USA).
Proliferation assay of T cells
Proliferative responses of lymph node (LN) cells from WT and
Olig1
2/2 mice on day 9 after MOG immunization were assayed
in microtiter wells by uptake of [
3H]thymidine as previously
reported [15]. LN cells (5610
5 cells/well) were cultured with given
concentrations of MOG35–55 for 3 days, with the last 18 h in the
presence of 0.5 mCi [
3H]thymidine. The cells were harvested on
glass-fiber filters, and the label uptake was determined using
standard liquid scintillation techniques.
Reverse transcription-polymerase chain reaction (RT-PCR)
analysis of Olig1 expression
RT-PCR analysis was performed as previously reported [15].
Total RNA of the brain, spinal cord, lymph node, spleen and
thymus was extracted with Isogen (Nippon Gene, Tokyo, Japan),
treated with DNase (RQ1 RNase-free Dnase; Promega, Madison,
WI, USA) and reverse-transcribed with Revertra ace (Toyobo,
Osaka, Japan) to obtain cDNA. The primer set used was as
follows: forward primer 59-AGC CAG CCC TCA CTT GGA
GAA CTG GGC CTG -39, reverse primer 59-TGC TGG GTA
GCT CGC TGC AGG AGC TGC GCC -39. The expected size
of Olig1 product was about 300 bp.
Immunoblot analysis
Immunoblotting were carried out as previously reported
[28,29]. Brains, optic nerves and spinal cords were freshly isolated
from 6 week- and 15 week-old WT and Olig1
2/2 mice, and then
homogenized. Samples were separated on a sodium dodecyl
sulfate-polyaclylamide gel electophoresis (SDS-PAGE) and subse-
quently transferred to an Immobilon-P filter (Millipore, Billerica,
MA, USA). Membranes were incubated with an antibody against
MOG (1:1,000; Abcam, Cambridge, MA, USA), myelin basic
protein (MBP; 1:1,000; Santa Cruz, Santa Cruz, CA, USA),
myelin-associated glycoprotein (MAG; 1:1,000; Santa Cruz),
myelin proteolipid protein (PLP; 1:1,000; Abcam, Cambridge,
MA), 29,39-cyclic nucleotide 39-phosphodiesterase (CNPase;
1:1,000; Sigma, St. Louis, MO), Olig2 (2 mg/ml; IBL, Gunma,
Japan) or actin Ab-5 (1:1,000; BD, Franklin Lakes, NJ, USA).
Quantitative real-time PCR analysis of Olig2 in spinal cord
Quantitative RT-PCR of spinal cord cDNA was performed
using the ABI 7500 fast real-time PCR system (Applied
Biosystems, Foster City, CA) with SYBR Green PCR Master
Mix (Applied Biosystems) as previously reported [15]. The primer
probe pair for Olig2 was: forward primer 59-CTG CTG GCG
CGA AAC TAC AT-39, reverse primer 59-CGC TCA CCA GTC
GCT TCA T-39.
Statistics
Data are presented as mean 6 s.e.m. When statistical analyses
are performed, Student’s t-test was used to estimate the
significance of the results.
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